These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29156704)

  • 1. ACKR3 expression on diffuse large B cell lymphoma is required for tumor spreading and tissue infiltration.
    Puddinu V; Casella S; Radice E; Thelen S; Dirnhofer S; Bertoni F; Thelen M
    Oncotarget; 2017 Oct; 8(49):85068-85084. PubMed ID: 29156704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACKR3 promotes CXCL12/CXCR4-mediated cell-to-cell-induced lymphoma migration through LTB4 production.
    Antonello P; Pizzagalli DU; Foglierini M; Melgrati S; Radice E; Thelen S; Thelen M
    Front Immunol; 2022; 13():1067885. PubMed ID: 36713377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study.
    Lemma SA; Pasanen AK; Haapasaari KM; Sippola A; Sormunen R; Soini Y; Jantunen E; Koivunen P; Salokorpi N; Bloigu R; Turpeenniemi-Hujanen T; Kuittinen O
    Eur J Haematol; 2016 May; 96(5):492-501. PubMed ID: 26153511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases.
    García-Cuesta EM; Santiago CA; Vallejo-Díaz J; Juarranz Y; Rodríguez-Frade JM; Mellado M
    Front Endocrinol (Lausanne); 2019; 10():585. PubMed ID: 31507535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-X-C Chemokine Receptor 4 in Diffuse Large B Cell Lymphoma: Achievements and Challenges.
    Du H; Gao L; Luan J; Zhang H; Xiao T
    Acta Haematol; 2019; 142(2):64-70. PubMed ID: 31096215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites.
    Wang C; Li W; Liu C; He H; Bai O
    Blood Cells Mol Dis; 2016 Mar; 57():42-9. PubMed ID: 26852654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical Chemokine Receptor 3 (ACKR3): A Comprehensive Overview of its Expression and Potential Roles in the Immune System.
    Koenen J; Bachelerie F; Balabanian K; Schlecht-Louf G; Gallego C
    Mol Pharmacol; 2019 Dec; 96(6):809-818. PubMed ID: 31040166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct Activation Mechanisms of CXCR4 and ACKR3 Revealed by Single-Molecule Analysis of their Conformational Landscapes.
    Schafer CT; Pauszek RF; Gustavsson M; Handel TM; Millar DP
    bioRxiv; 2024 Jun; ():. PubMed ID: 37961571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma].
    Zhang C; Cui GH; Liu F; Wu QL; Chen Y
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):695-7. PubMed ID: 17553309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell immunoglobulin mucin molecule-3, transformation growth factor β, and chemokine-12 and the prognostic status of diffuse large B-cell lymphoma.
    Wu H; Sun HC; Ouyang GF
    World J Clin Cases; 2022 Nov; 10(32):11804-11811. PubMed ID: 36405294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Preclinical Model of Inflammatory Breast Cancer to Study the Involvement of CXCR4 and ACKR3 in the Metastatic Process.
    Wurth R; Tarn K; Jernigan D; Fernandez SV; Cristofanilli M; Fatatis A; Meucci O
    Transl Oncol; 2015 Oct; 8(5):358-367. PubMed ID: 26500026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilayer lipids modulate ligand binding to atypical chemokine receptor 3.
    Eberle SA; Gustavsson M
    Structure; 2024 May; ():. PubMed ID: 38776922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era.
    Takahashi H; Tomita N; Yokoyama M; Tsunoda S; Yano T; Murayama K; Hashimoto C; Tamura K; Sato K; Ishigatsubo Y
    Cancer; 2012 Sep; 118(17):4166-72. PubMed ID: 22213346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy.
    Shin HC; Seo J; Kang BW; Moon JH; Chae YS; Lee SJ; Lee YJ; Han S; Seo SK; Kim JG; Sohn SK; Park TI
    Korean J Intern Med; 2014 Nov; 29(6):785-92. PubMed ID: 25378977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the CD20 and CXCR4 pathways in non-hodgkin lymphoma with rituximab and high-affinity CXCR4 antagonist BKT140.
    Beider K; Ribakovsky E; Abraham M; Wald H; Weiss L; Rosenberg E; Galun E; Avigdor A; Eizenberg O; Peled A; Nagler A
    Clin Cancer Res; 2013 Jul; 19(13):3495-507. PubMed ID: 23637121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells.
    Venetz D; Ponzoni M; Schiraldi M; Ferreri AJ; Bertoni F; Doglioni C; Uguccioni M
    Int J Cancer; 2010 Nov; 127(10):2300-12. PubMed ID: 20872671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
    Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
    Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination.
    López-Giral S; Quintana NE; Cabrerizo M; Alfonso-Pérez M; Sala-Valdés M; De Soria VG; Fernández-Rañada JM; Fernández-Ruiz E; Muñoz C
    J Leukoc Biol; 2004 Aug; 76(2):462-71. PubMed ID: 15155773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas.
    Deutsch AJ; Aigelsreiter A; Steinbauer E; Frühwirth M; Kerl H; Beham-Schmid C; Schaider H; Neumeister P
    J Pathol; 2008 Aug; 215(4):431-44. PubMed ID: 18561120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.